ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Alzheimer's disease, a metabolic disorder: Clinical advances and basic model studies (Review)

Zhou, Shanhu; Tu, Limin; Chen, Wei; Yan, Gangli; Guo, Hongmei; Wang, Xinhua; Hu, Qian; Liu, Huiqing*; Li, Fengguang*1
Experimental and Therapeutic Medicine2024-2DOI: 10.3892/etm.2023.12351
8阅读
引用收藏
分享

摘要

Alzheimer's disease (AD) is a type of neurodegenerative disease characterized by cognitive impairment that is aggravated with age. The pathological manifestations include extracellular amyloid deposition, intracellular neurofibrillary tangles and loss of neurons. As the world population ages, the incidence of AD continues to increase, not only posing a significant threat to the well-being and health of individuals but also bringing a heavy burden to the social economy. There is epidemiological evidence suggesting a link between AD and metabolic diseases, which share pathological similarities. This potential link would deserve further consideration; however, the pathogenesis and therapeutic efficacy of AD remain to be further explored. The complex pathogenesis and pathological changes of AD pose a great challenge to the choice of experimental animal models. To understand the role of metabolic diseases in the development of AD and the potential use of drugs for metabolic diseases, the present article reviews the research progress of the comorbidity of AD with diabetes, obesity and hypercholesterolemia, and summarizes the different roles of animal models in the study of AD to provide references for researchers.

学科与关键词

关键词
Alzheimer's diseasemetabolic diseasediabetesobesityhypercholesterolemiaanimal models
相关
加载中…
  • Comparative Metabolomics Analysis Reveals Key Metabolic Mechanisms and Protein Biomarkers in Alzheimer's Disease
    Dai, Zhao; Hu, Tian; Su, Shijie; Liu, Jinman; Ma, Yinzhong; Zhuo, Yue; Fang, Shuhuan; Wang, Qi; Mo, Zhizhun*; Pan, Huafeng*; Fang, Jiansong*Frontiers in Pharmacology, 2022, 13: 904857.被引 6
  • The mechanism and efficacy of GLP-1 receptor agonists in the treatment of Alzheimer's disease
    Du, Haiyang; Meng, Xiaoyu; Yao, Yu; Xu, Jun*Frontiers in Endocrinology, 2022, 13: 1033479.被引 8
  • Clinical Neurophysiological and Automated EEG-Based Diagnosis of the Alzheimer's Disease
    Bhat, Shreya; Acharya, U. Rajendra*; Dadmehr, Nahid; Adeli, HojjatEuropean Neurology, 2015, 74(3-4): 202-210.被引 44
查看全部 →

发表信息

论文状态
公开发表
期刊
Experimental and Therapeutic Medicine
发表日期
2024-02
卷期
第 27 卷, 第 2 期
页码
63
DOI
10.3892/etm.2023.12351
语言
ENGLISH
成果收录
SCIE
资助标注
General Project of the Natural Science Foundation of Hubei Province [2021CFB585]; General Project of Health Commission of Hubei Province [WJ2021M030]

作者

  • Z

    Zhou, Shanhu (第一作者)

    1 · wuhan univ sci & technol

  • T

    Tu, Limin

    1 · wuhan univ sci & technol

查看全部 9 位作者收起作者
  • C

    Chen, Wei

    1 · wuhan univ sci & technol

  • Y

    Yan, Gangli

    1 · wuhan univ sci & technol

  • G

    Guo, Hongmei

    1 · wuhan univ sci & technol

  • W

    Wang, Xinhua

    1 · wuhan univ sci & technol

  • H

    Hu, Qian

    1 · wuhan univ sci & technol

  • L

    Liu, Huiqing (通讯)

    1 · wuhan univ sci & technol

  • L

    Li, Fengguang (通讯)

    1 · wuhan univ sci & technol

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417